Wednesday, July 8, 2026
🇺🇸 FDA

Patent directory · USPTO A61K / A61P

Patents matching “The United States of America”

3,063 pharma patents match "The United States of America" in our USPTO index (A61K/A61P) — applicant, grant date, expiration, and drug links.

Matches 3,063
Index total 30,257
Page 30 / 128

Quick answer

This filtered view shows 3,063 pharmaceutical patents matching "The United States of America" in our USPTO PatentsView index (CPC A61K/A61P). Search matches patent number, title, applicant, and CPC classification codes.

Patent results

3,063 results for “The United States of America” · 30,257 patents in full index Clear search

  1. US 10308927

    Processing of a modified foot-and-mouth disease virus P1 polypeptide by an alternative protease

    The United States of America, as represented by the Secretary of Homeland Security · Granted Jun 4, 2019 · Expires May 30, 2039

    granted

  2. US 10307469

    Synthetic methylmalonyl-CoA mutase transgene for the treatment of MUT class methylmalonic acidemia (MMA)

    The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Jun 4, 2019 · Expires May 30, 2039

    granted

  3. US 10307477

    Methods for inducing an immune response against human immunodeficiency virus infection in subjects undergoing antiretroviral treatment

    The United States of America as represented by the Secretary of the Army · Granted Jun 4, 2019 · Expires May 30, 2039

    granted

  4. US 10308591

    Preparation of (R,R)-fenoterol and (R,R)- or (R,S)-fenoterol analogues and their use in treating congestive heart failure

    The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Jun 4, 2019 · Expires May 30, 2039

    granted

  5. US 10300095

    AAV mediated exendin-4 gene transfer to salivary glands to protect subjects from diabetes or obesity

    The United States of America as Represented by the Secretary, Dept. of Health and Human Services · Granted May 28, 2019 · Expires May 23, 2039

    granted

  6. US 10301314

    Compounds and methods for the prevention and treatment of tumor metastasis and tumorigenesis

    The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted May 28, 2019 · Expires May 23, 2039

    granted

  7. US 10301621

    Multifunctional RNA nanoparticles and methods of use

    The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted May 28, 2019 · Expires May 23, 2039

    granted

  8. US 10300115

    Methods and compositions for modulating immune tolerance

    The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted May 28, 2019 · Expires May 23, 2039

    granted

  9. US 10301377

    Middle east respiratory syndrome coronavirus immunogens, antibodies, and their use

    The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted May 28, 2019 · Expires May 23, 2039

    granted

  10. US 10293005

    Use of gram negative species to treat atopic dermatitis

    The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted May 21, 2019 · Expires May 16, 2039

    granted

  11. US 10294483

    Eimeria tenella elongation factor-1 alpha recombinant immunogenic compositions which induce active protective immunity against avian coccidiosis

    The United States of America, as represented by the Secretary of Agriculture · Granted May 21, 2019 · Expires May 16, 2039

    granted

  12. US 10287297

    Epoxyazulene derivatives useful for treating cancer and diabetes

    The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted May 14, 2019 · Expires May 9, 2039

    granted

  13. US 10287279

    Inhibitors of human 12/15-lipoxygenase

    The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted May 14, 2019 · Expires May 9, 2039

    granted

  14. US 10287350

    Chimeric antigen receptors targeting CD-19

    The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted May 14, 2019 · Expires May 9, 2039

    granted

  15. US 10287340

    Anti-HIV domain antibodies and method of making and using same

    The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted May 14, 2019 · Expires May 9, 2039

    granted

  16. US 10286064

    Cationic lipid vaccine compositions and methods of use

    THE UNITED STATES OF AMERICA AS REPRESENTED BY THE SEC. OF THE DEPT. OF HEALTH AND HUMAN SERVICES · Granted May 14, 2019 · Expires May 9, 2039

    granted

  17. US 10286050

    Multi-epitope TARP peptide vaccine and uses thereof

    The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted May 14, 2019 · Expires May 9, 2039

    granted

  18. US 10280307

    Class of stable heptamethine cyanine fluorophores and biomedical applications thereof

    The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted May 7, 2019 · Expires May 2, 2039

    granted

  19. US 10281475

    Systems and methods to identify and treat subjects at risk for obstetrical complications

    The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted May 7, 2019 · Expires May 2, 2039

    granted

  20. US 10273288

    Neutralizing antibodies to Ebola virus glycoprotein and their use

    The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Apr 30, 2019 · Expires Apr 25, 2039

    granted

  21. US 10272039

    Topical sodium nitrite formulation

    The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Apr 30, 2019 · Expires Apr 25, 2039

    granted

  22. US 10273291

    Focused evolution of HIV-1 neutralizing antibodies revealed by crystal structures and deep sequencing

    THE UNITED STATES OF AMERICA, AS REPRESENTED BY THE SECRETARY, DEPARTMENT OF HEALTH AND HUMAN SERVICES, OFFICE OF TECHNOLOGY TRANSFER—NATIONAL INSTITUTES OF HEALTH · Granted Apr 30, 2019 · Expires Apr 25, 2039

    granted

  23. US 10273299

    Antibodies to tumor endothelial marker 8

    The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Apr 30, 2019 · Expires Apr 25, 2039

    granted

  24. US 10272163

    Factor VIII mutation repair and tolerance induction

    THE UNITED STATES OF AMERICA REPRESENTED BY THE DEPARTMENT OF VETERANS AFFAIRS · Granted Apr 30, 2019 · Expires Apr 25, 2039

    granted

Drug approvals, clinical trials, M&A, event intelligence, and company updates — weekly.

Customize topics & region
Topics
Region

No spam. Unsubscribe anytime. See our privacy policy.